RXFP2
Basic information
Region (hg38): 13:31739526-31803389
Previous symbols: [ "LGR8" ]
Links
Phenotypes
GenCC
Source:
- cryptorchidism (Limited), mode of inheritance: AR
- disorder of sexual differentiation (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Cryptorchidism | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Genitourinary | 12217959; 12970298 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (85 variants)
- not_provided (7 variants)
- Bilateral_cryptorchidism (2 variants)
- RXFP2-related_disorder (2 variants)
- Disorder_of_sexual_differentiation (1 variants)
- Cryptorchidism (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RXFP2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000130806.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 1 | 2 | |||
| missense | 1 | 83 | 9 | 93 | ||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 1 | 1 | 84 | 10 | 0 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| RXFP2 | protein_coding | protein_coding | ENST00000298386 | 18 | 63336 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 125631 | 0 | 117 | 125748 | 0.000465 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.894 | 345 | 395 | 0.873 | 0.0000197 | 5002 |
| Missense in Polyphen | 82 | 108.74 | 0.7541 | 1418 | ||
| Synonymous | 0.234 | 140 | 144 | 0.975 | 0.00000802 | 1382 |
| Loss of Function | 1.54 | 29 | 39.4 | 0.736 | 0.00000206 | 481 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000962 | 0.000962 |
| Ashkenazi Jewish | 0.000300 | 0.000298 |
| East Asian | 0.00125 | 0.00125 |
| Finnish | 0.0000924 | 0.0000924 |
| European (Non-Finnish) | 0.000503 | 0.000501 |
| Middle Eastern | 0.00125 | 0.00125 |
| South Asian | 0.000131 | 0.000131 |
| Other | 0.000329 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for relaxin. The activity of this receptor is mediated by G proteins leading to stimulation of adenylate cyclase and an increase of cAMP. May also be a receptor for Leydig insulin-like peptide (INSL3).;
- Pathway
- Relaxin signaling pathway - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);Myometrial Relaxation and Contraction Pathways;Signaling by GPCR;Signal Transduction;G alpha (s) signalling events;Relaxin receptors;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.126
Intolerance Scores
- loftool
- 0.569
- rvis_EVS
- -0.18
- rvis_percentile_EVS
- 40.56
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0535
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- oocyte maturation;G protein-coupled receptor signaling pathway;adenylate cyclase-activating G protein-coupled receptor signaling pathway;activation of adenylate cyclase activity;adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway;negative regulation of cell population proliferation;male gonad development;hormone-mediated signaling pathway;negative regulation of apoptotic process;positive regulation of cAMP-mediated signaling
- Cellular component
- plasma membrane;integral component of plasma membrane
- Molecular function
- G protein-coupled peptide receptor activity;protein-hormone receptor activity;peptide hormone binding